The Veterinary Medicines Directorate has agreed to a request from Elanco to recategorise Zolvix 25mg/ml Oral Solution - licensed for the treatment and control of gastro-intestinal nematode infections and associated diseases of sheep - from POM-V to POM-VPS.The Veterinary Medicines Directorate has agreed to a request from Elanco to recategorise Zolvix 25mg/ml Oral Solution - licensed for the treatment and control of gastro-intestinal nematode infections and associated diseases of sheep - from POM-V to POM-VPS.

The recategorisation means that pharmacists and Suitably Qualified Persons (SQPs) will be able to prescribe Zolvix.

The VMD says that making the anthelmintic more widely available will increase its usage as part of strategic worm control programmes on farms, which could in turn result in long term health benefits for sheep, for example by reducing the development and spread of anthelmintic resistance, thereby prolonging the effective use of anthelmintics.

The VMD adds that SQPs will now have additional training to ensure they are sufficiently familiar with Zolvix and how to prescribe it effectively and responsibly so that it is used appropriately. A new compulsory training module will be implemented by The Animal Medicines Training Regulatory Authority (AMTRA) to augment the skills of all AMTRA-registered SQPs permitted to prescribe farm animal products. New SQPs will be required to undertake a revised and extended module before gaining their farm animal registration with AMTRA.

Pharmacists and SQPs will be able to prescribe Zolvix from 1st July 2017.


UPDATE 16th March: 

BVA President Gudrun Ravetz has issued a statement expressing concern over the recategorisation of Zolvix:

"We know that resistance to anthelmintics is increasing in grazing animals and needs to be addressed if the livestock industry is to avoid a potentially disastrous situation of being unable to tackle parasites. The reclassification of Zolvix from POM-V to POM-VPS is in direct opposition to the trend in Europe, where we are seeing increased control over dispensing of anthelmintics in species where resistance is a serious threat to animal welfare and profitable production; we're extremely concerned that we might start seeing resistance develop in group 4 as a result.

"BVA believes that prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis, in order to protect animal welfare and safeguard the efficacy of these products for the future."

Further information on BVA's policy on anthelmintics can be found on BVA’s website: www.bva.co.uk/news-campaigns-and-policy/policy/medicines/anthelmintics.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.